Chengdu Easton Biopharmaceuticals Co., Ltd. Class ASSE: 688513

"Chengdu Easton Biopharmaceuticals Co., Ltd."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

· Issued by Chengdu Easton Biopharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange

Filed with SSE ·

Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Innovative Drug Industry

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Company analysis

Earlier from Chengdu Easton Biopharmaceuticals Co., Ltd. Class A

All Chengdu Easton Biopharmaceuticals Co., Ltd. Class A news releases